|
Q3 2020
Filed on Nov 12, 2020
|
100,000
|
N/A
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
50,000
|
$4.16 - $6.26
$208K - $313K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
14,179
|
$104.81 - $145.33
$1.49M - $2.06M
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
54,160
|
$10.4 - $15.9
$563K - $861K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
50,000
|
N/A
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
850,000
|
N/A
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
5,000
|
$39.85 - $57.3
$199K - $287K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
100,000
|
$2.77 - $6.17
$277K - $617K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
50,000
|
$2.33 - $4.94
$117K - $247K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
40,000
|
$4.38 - $6.43
$175K - $257K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
19,594
|
$113.85 - $136.03
$2.23M - $2.67M
|
|
Adamas Pharmaceuticals Inc
|
Q3 2020
Filed on Nov 12, 2020
|
100,000
|
N/A
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
10,000
|
$24.19 - $31.21
$242K - $312K
|
|
Axovant Gene Therapies LTD
|
Q3 2020
Filed on Nov 12, 2020
|
50,000
|
N/A
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
21,360
|
$37.44 - $64.63
$800K - $1.38M
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
96,800
|
$3.43 - $5.53
$332K - $535K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
87,782
|
$2.85 - $4.1
$250K - $360K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
50,000
|
N/A
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
70,000
|
$3.5 - $7.62
$245K - $533K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
105,000
|
$4.19 - $6.69
$440K - $702K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
25,940
|
$11.55 - $23.75
$300K - $616K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
30,000
|
$17.61 - $31.86
$528K - $956K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
20,000
|
$6.17 - $18.82
$123K - $376K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
746,804
|
N/A
|
|
Trillium Therapeutics Inc
|
Q3 2020
Filed on Nov 12, 2020
|
25,984
|
N/A
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
43,172
|
$2.94 - $12.43
$127K - $537K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
101,975
|
N/A
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
60,000
|
$4.45 - $10.2
$267K - $612K
|
|
Xeris Pharmaceuticals Inc
|
Q3 2020
Filed on Nov 12, 2020
|
61,542
|
N/A
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
2,025
|
$117.57 - $154.5
$238K - $313K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
313,889
|
$4.0 - $7.53
$1.26M - $2.36M
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
35,627
|
$55.23 - $62.39
$1.97M - $2.22M
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
30,000
|
$2.39 - $13.08
$71.7K - $392K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
854,250
|
N/A
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
28,336
|
N/A
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
541,203
|
$2.18 - $2.84
$1.18M - $1.54M
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
304,654
|
$3.64 - $7.76
$1.11M - $2.36M
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
5,150
|
$73.46 - $94.3
$378K - $486K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
20,000
|
$14.05 - $22.6
$281K - $452K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
45,000
|
$4.36 - $5.5
$196K - $248K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
400,000
|
$1.91 - $3.08
$764K - $1.23M
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
200,000
|
$1.21 - $2.23
$242K - $446K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
4,550
|
$64.59 - $77.31
$294K - $352K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
118,299
|
$3.01 - $5.01
$356K - $593K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
40,512
|
$4.12 - $9.09
$167K - $368K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
8,308
|
$29.35 - $37.89
$244K - $315K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
15,000
|
$9.8 - $16.53
$147K - $248K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
4,000
|
$52.87 - $67.08
$211K - $268K
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
10,000
|
N/A
|
|
|
Q3 2020
Filed on Nov 12, 2020
|
60,000
|
$12.89 - $15.89
$773K - $953K
|
|